Last updated: April 4, 2022
Sponsor: University Hospital, Clermont-Ferrand
Overall Status: Active - Recruiting
Phase
N/A
Condition
Hypertriglyceridemia
Obesity
Treatment
N/AClinical Study ID
NCT05319704
RBHP 2018 RICHARD
2019-A00082-55
Ages 20-40 Male Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Male volunteers between 20 and 40 years old (20 ≥ years ≤ 40)
- Subjects considered healthy by investigator based on the examination, medical andclinical examination
- Body Mass Index between 27 and 35 kg/m² (27 < BMI < 35)
- Biological check up considered compatible with study participation
- Physical check up considered compatible with study participation (no bones, articularor muscular problems)
- Person who don't smoke and has no treatment
- Person who is in the position to sign informed consent
Exclusion
Exclusion Criteria:
- Smoking
- Person who take any kind of treatments except Paracétamol
- All conditions who have interaction with this clinical trial, or who can deterioratethe exercise capacity or the realization of canopy (claustrophobia)
- Criteria
- Administrative and legal factors
- Person who isn't consent
- Subject not affiliated with social security
- Subject during the exclusion period of a previous study (after verification in theBiomedical Research Volunteers File).
Study Design
Total Participants: 12
Study Start date:
February 17, 2021
Estimated Completion Date:
August 31, 2023
Study Description
Connect with a study center
CHU clermont-ferrand
Clermont-Ferrand,
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.